Open AccessA randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas
Author(s) -
Lu Ni,
Weihan Zhang,
Ye Chen,
Weibing Leng,
Hongfeng Gou,
JianKun Hu,
Meng Qiu
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025493
Subject(s) - capecitabine , medicine , oxaliplatin , docetaxel , clinical endpoint , gastroenterology , progression free survival , toxicity , oncology , phases of clinical research , cancer , randomized controlled trial , chemotherapy , surgery , colorectal cancer